Artiva Biotherapeutics Appoints Edith A. Perez, M.D., to Its Board of Directors and Clinical Advisory Board

by on May 5, 2022

SAN DIEGO, May 5, 2022 — Artiva Biotherapeutics, Inc., an oncology company whose mission is to deliver highly effective, off-the-shelf, allogeneic natural killer (NK) cell-based therapies that are safe and accessible to cancer patients, today announced the appointment of Edith A. Perez, M.D., as a member of the Company’s Board of Directors. In addition, Dr….